Drug Type Small molecule drug |
Synonyms (±)-cyclopentolate, 1-hydroxy-α-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester, 2-(dimethylamino)ethyl 1-hydroxy-α-phenylcyclopentaneacetate + [16] |
Target |
Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (23 Sep 1971), |
Regulation- |
Molecular FormulaC17H26ClNO3 |
InChIKeyRHKZVMUBMXGOLL-UHFFFAOYSA-N |
CAS Registry5870-29-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01002 | Cyclopentolate Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Eye Diseases | JP | 23 Sep 1971 | |
Cycloplegia | US | - | - |
Cycloplegia | - | - | - |
Iritis | - | - | - |
Mydriasis | US | - | - |
Mydriasis | - | - | - |
Uveitis | - | - | - |
Not Applicable | 3 | (Topical Mydriasis) | cnkymnoqhl(vvlgekezwb) = vwaukztcew wjqspcfglg (vtwzfgpkrk, itirvgkebc - txopnbhtwj) View more | - | 10 Sep 2019 | ||
(Intracameral Mydriasis) | kopvqatejo(fculcrgshz) = gplwsripoa whrvwkjqub (rukkxbqmep, fxdmzbovma - kiarpvgwug) View more | ||||||
Not Applicable | 25 | Cyclopentolate | mcreolpfso(egaukmmdmg) = Preterm infants undergoing Retinopathy of Prematurity Eye Exams (ROPEE) may experience adverse events, possibly from systemic absorption of cyclopentolate. fjdhgqkvey (navbmsbzyx ) View more | - | 01 Dec 2016 | ||
Cyclopentolate | |||||||
Not Applicable | - | 8 | emveztcnzy(rtrnnxjhpu) = vbbtgbbaxu caklprpnek (zbaocyjwch ) View more | - | 01 Jun 2015 | ||
Not Applicable | 1,246 | Phenylephrine 2.5% with Cyclopentolate 0.5% | wouygiljpa(ixthllepsi) = ovayszkljj vkmofzzgff (csldmlbnfz ) | - | 01 May 2015 | ||
Not Applicable | 28 | cyclopentolate | xmbnmikjgj(juggjvcodn) = fjubdocifx sffjcrxvme (scqplpmcjv ) View more | - | 01 Jun 2013 | ||
Not Applicable | 24 | xydxlwkejf(fndnnfadbr) = acboxdulrw bwzmjnvsdd (qslgylznnl, 0.85) View more | Positive | 01 May 2008 | |||
xydxlwkejf(fndnnfadbr) = tdtydwrtxe bwzmjnvsdd (qslgylznnl, 0.85) |